"FDA approval of BioIntelliSense’s patient monitoring system signals major progress in remote patient monitoring market" was ...

Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

Late last month, Boston Scientific announced it was pausing ... to continue was made in conjunction with the trial’s data monitoring committee. In an interview with Fierce Medtech following ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

TMOThermo Fisher Scientific Inc.